MCD Group continuously researches and monitors emerging drug delivery technologies and has compiled this report to profile some of the innovative developments at younger, emerging companies. The report focuses on start-ups and smaller companies that tend to be less well known, but are expected to gain momentum as they advance their technologies and produce significant clinical data. All of the companies profiled have interest in forming new partnerships or receiving funding to enable further development and eventual commercialization of their technologies.
The report features profiles of 62 companies, a majority of which were founded in the past five years. Most are located in the United States; however a few profiled companies are based in Canada, Europe, and Australia. Approximately 50% of the companies are affiliated with a University, and ten companies have initiated human clinical trials.
Collectively, the emerging companies profiled in this report are focused on 11 different therapeutic categories. Oncology is the leading focus among companies investigated, and approximately 25 percent of the companies profiled are developing proprietary technologies designed to improve delivery of macromolecules/biologics. Another 25 percent of the companies are focused on novel delivery devices, ranging from inhalation and nasal devices, to more patient-friendly injectable systems. All of the companies investigated are developing technologies that could potentially transform drug delivery in one or more therapeutic areas.
For each company profiled, the following information is provided:
Sample of Companies Profiled
|Convoy Therapeutics||Orbis Biosciences|
|Corinthian Ophthalmic||Qrono, Inc.|
|Inspiro Medical||ZetrOZ, LLC|
We specialize in life science industry reports and customized consulting services for pharmaceutical, biotechnology and drug delivery companies. The company's industry reports provide timely and accurate technology and market intelligence, and can serve as a valuable tool in the identification and evaluation of drug delivery product and technology partnering opportunities.
Browse more Drug Delivery System Market Research Reports